BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20646515)

  • 1. [Application of positron emission tomography in evaluation of Alzheimer's disease rat model].
    He TT; Zhang JM; Wang RM; Yao SL; Tian JH
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):924-7. PubMed ID: 20646515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
    Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
    Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography imaging of cell transplantation in a rat model of Alzheimer's disease].
    He TT; Zhang JM; Shen L; Yao SL; Tian JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):210-4. PubMed ID: 20450555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
    Carneiro CG; Faria DP; Coutinho AM; Ono CR; Duran FLS; da Costa NA; Garcez AT; da Silveira PS; Forlenza OV; Brucki SMD; Nitrini R; Busatto G; Buchpiguel CA
    Braz J Psychiatry; 2022 Aug; 44(5):495-506. PubMed ID: 36420910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
    Bunai T; Kakimoto A; Yoshikawa E; Terada T; Ouchi Y
    J Alzheimers Dis; 2019; 69(2):529-538. PubMed ID: 31104023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
    Nam MH; Ko HY; Kim D; Lee S; Park YM; Hyeon SJ; Won W; Chung JI; Kim SY; Jo HH; Oh KT; Han YE; Lee GH; Ju YH; Lee H; Kim H; Heo J; Bhalla M; Kim KJ; Kwon J; Stein TD; Kong M; Lee H; Lee SE; Oh SJ; Chun JH; Park MA; Park KD; Ryu H; Yun M; Lee CJ
    Brain; 2023 Jul; 146(7):2957-2974. PubMed ID: 37062541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.
    Verhoeff NP; Wilson AA; Takeshita S; Trop L; Hussey D; Singh K; Kung HF; Kung MP; Houle S
    Am J Geriatr Psychiatry; 2004; 12(6):584-95. PubMed ID: 15545326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.
    Pan ML; Mukherjee MT; Patel HH; Patel B; Constantinescu CC; Mirbolooki MR; Liang C; Mukherjee J
    Synapse; 2016 Apr; 70(4):163-76. PubMed ID: 26806100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study.
    Wang Y; Shi Z; Zhang N; Cai L; Li Y; Yang H; Yao S; Xing X; Ji Y; Gao S
    Mol Imaging Biol; 2019 Feb; 21(1):140-148. PubMed ID: 29869063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?
    Oliveira FPM; Moreira AP; de Mendonça A; Verdelho A; Xavier C; Barroca D; Rio J; Cardoso E; Cruz Â; Abrunhosa A; Castelo-Branco M
    J Alzheimers Dis; 2018; 65(1):89-97. PubMed ID: 30056421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labeling.
    Filip T; Mairinger S; Neddens J; Sauberer M; Flunkert S; Stanek J; Wanek T; Okamura N; Langer O; Hutter-Paier B; Kuntner C
    Alzheimers Res Ther; 2021 Oct; 13(1):175. PubMed ID: 34656177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
    Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
    J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
    Villemagne VL; Ataka S; Mizuno T; Brooks WS; Wada Y; Kondo M; Jones G; Watanabe Y; Mulligan R; Nakagawa M; Miki T; Shimada H; O'Keefe GJ; Masters CL; Mori H; Rowe CC
    Arch Neurol; 2009 Dec; 66(12):1537-44. PubMed ID: 20008660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography.
    Maeda J; Ji B; Irie T; Tomiyama T; Maruyama M; Okauchi T; Staufenbiel M; Iwata N; Ono M; Saido TC; Suzuki K; Mori H; Higuchi M; Suhara T
    J Neurosci; 2007 Oct; 27(41):10957-68. PubMed ID: 17928437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular injection of Aβ
    Dai SJ; Zhang JY; Bao YT; Zhou XJ; Lin LN; Fu YB; Zhang YJ; Li CY; Yang YX
    Pathol Res Pract; 2018 Oct; 214(10):1583-1595. PubMed ID: 30087036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study.
    Lu Y; Ren J; Cui S; Chen J; Huang Y; Tang C; Shan B; Nie B; Xinsheng L
    Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):333-40. PubMed ID: 26631686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.